Industry complaining government's subsidy cut off for new drug R&D.

The pharmaceutical industry sensitively concerned about the government budgeting plans for the new drug R&D subsidy to skip. The MOHW budget amounting to the total 89,200 million won for the first half of 2003 did not include any new projects of the new drug R&D.

In fact the MOHW budget allocated merely 66,700 million won, only 2,700 million won up from the previous year, for the health, m...